“Analysis of Azithromycin adverse events in COVID-19 Patients reported to Iraqi Pharmacovigilance center in 2020” (2022) Al Mustansiriyah Journal of Pharmaceutical Sciences, 22(3), pp. 35–42. doi:10.32947/ajps.v22i3.887.